Literature DB >> 15894504

[Incidents of blood donation].

B Danic1, H Gouézec, E Bigant, T Thomas.   

Abstract

In France, more than two million blood donations are needed for transfusion each year. The rules and requirements for blood donors selection are strict and aim to protect the donors' health as well as the patients'security. However, the review of the literature shows that adverse effects of blood withdrawal occur quite frequently. They can be classified in immediate or delayed events, or local (hematoma, nerve injury, arterial puncture injury, allergy, veinitis, thrombosis) and general reactions (vasovagal reaction, citrate toxicity, cardiovascular failure, allergy to ethylene oxide, adverse effects of drugs used for some types of donation). This article reviews the principal adverse events described in the literature and concludes with the necessity to set up hemovigilance for donors, as defined in directive 2002/98/EC of the European parliament and of the council.

Entities:  

Mesh:

Year:  2005        PMID: 15894504     DOI: 10.1016/j.tracli.2005.04.003

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  3 in total

1.  Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil.

Authors:  Thelma T Gonçalez; Ester C Sabino; Karen S Schlumpf; David J Wright; Silvana Leao; Divaldo Sampaio; Pedro L Takecian; Anna B Proietti; Anna B Proitetti; Edward Murphy; Michael Busch; Brian Custer
Journal:  Transfusion       Date:  2011-11-11       Impact factor: 3.157

2.  Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study.

Authors:  Antonio Crocco; Domenico D'Elia
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

3.  Incidence, predictors and severity of adverse events among whole blood donors.

Authors:  Hamdan Almutairi; Mahmoud Salam; Abdulaziz Alajlan; Faisal Wani; Bushra Al-Shammari; Khaled Al-Surimi
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.